Please use this identifier to cite or link to this item:
Title: Study of the transport of substances across the blood-brain barrier with the 8D3 anti-transferrin receptor antibody
Author: Cabezón Rodríguez, Itsaso
Augé Marí, Elisabet
Camins Espuny, Antoni
Vilaplana i Hortensi, Jordi
Pelegrí i Gabaldà, Carme
Keywords: Fisiologia animal
Barrera hematoencefàlica
Animal physiology
Blood-brain barrier
Issue Date: 2018
Publisher: Research Signpost
Abstract: Numerous strategies have been proposed to overcome the blood-brain barrier (BBB) and efficiently deliver therapeutic agents to the brain. One of these strategies consists of linking the pharmacologically active substance to a molecular vector that acts as a molecular Trojan Horse and is capable of crossing the BBB using a receptor-mediated transcellular transport system of the brain capillary endothelial cells (BCECs). The transferrin receptor (TfR) is related to a transcytosis process in these cells, and the 8D3 monoclonal antibody (mAb), directed against the mouse TfR, is able to induce a receptor response. Thus, the 8D3 antibody could be a potential molecular Trojan Horse to transport pharmacologically active substances across the BBB. On these bases, a series of experiments were performed where the 8D3 antibody was conjugated to different cargoes, the resulting constructs were administered in vivo to mice, and the distribution and intracellular mechanisms that these constructs undergo at the BBB were studied. Our results indicated a TfR-mediated and clathrin-dependent internalization process by which the 8D3-cargo constructs enters the BCEC. The resulting endocytic vesicles follow at least two different routes. On one hand, most vesicles enter intracellular processes of vesicular fusion and rearrangement in which the cargo is guided to late endosomes, multivesicular bodies or lysosomes. On the other hand, a small but not negligible percentage of the vesicles follow a different route in which they fuse with the abluminal membrane and open towards the basal lamina, indicating a potential route for the delivery of therapeutic substances. In this route, however, the 8D3−cargo remain fixed to the abluminal membrane, indicating that the 8D3 is maintained linked to the TfR, and the cargo does not go beyond the basal membrane. Altogether, different optimization approaches need to be developed for efficient drug delivery, but receptor-mediated transport (RMT) continues to be one of the most promising strategies to overcome the BBB.
Note: Podeu consultar el llibre complet a:
Note: Reproducció del capítol del llibre publicat a:
It is part of: Recent Advances in Pharmaceutical Sciences VIII, 2018, Research Signpost. Editors: Diego Muñoz-Torrero, Yolanda Cajal and Joan Maria Llobet. ISBN: 978-81-308-0579-5. Chapter 4, p. 59-78
Related resource:
Appears in Collections:Llibres / Capítols de llibre (Bioquímica i Fisiologia)
Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
T_1548757000munoz 4.pdf822.33 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons